Penfill and alanine aminotransferase increased Patient Reports February 09, 2010

Penfill Side Effects Report #5719406-3
Penfill side effect was reported by a Physician from JAPAN on Apr 15, 2008. Male patient, 50 years of age, weighting 125.2 lb, was diagnosed with type 1 diabetes mellitus and was treated with Penfill. After drug was administered, patient experienced the following side effects: agitation, alanine aminotransferase increased, aspartate aminotransferase increased, diabetic hyperglycaemic coma, goitre, hepatomegaly, hypoglycaemia, intentional overdose, suicide attempt. Penfill dosage: unknown. Patient recovered.

Penfill Side Effects Report #5130377-3
Penfill side effect was reported by a Physician from JAPAN on Mar 06, 2006. Female patient, 46 years of age, weighting 121.3 lb, was diagnosed with ketoacidosis and was treated with Penfill. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, liver disorder. Penfill dosage: unknown. During the same period patient was treated with PENFILL N CHU, NOVORAPID CHU, LANTUS. Patient was hospitalized. Patient recovered.

Penfill Side Effects Report #4944171-7
Penfill side effect was reported by a Physician from JAPAN on Mar 06, 2006. Female patient, 46 years of age, weighting 121.3 lb, was diagnosed with ketoacidosis and was treated with Penfill. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. Penfill dosage: unknown. During the same period patient was treated with PENFILL N CHU, NOVORAPID CHU, LANTUS. Patient was hospitalized. Patient recovered.

Penfill Side Effects Report #4582515-9
Penfill side effect was reported by a Physician from on Feb 03, 2005. Male patient, 58 years of age, weighting 112.4 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with Penfill. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, hepatic function abnormal. Penfill dosage: unknown. During the same period patient was treated with KINEDAK, GLIMICRON. Patient was hospitalized. Patient recovered.


Penfill Side Effects Report #4639186-2
Penfill side effect was reported by a Consumer or non-health professional from on Apr 08, 2005. Male patient, 45 years of age, weighting 127.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with Penfill. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, liver function test abnormal. Penfill dosage: unknown. Patient was hospitalized. Patient recovered.